Compare PEPG & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEPG | AGL |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.3M | 5.3M |
| IPO Year | 2022 | 2021 |
| Metric | PEPG | AGL |
|---|---|---|
| Price | $1.72 | $30.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 12 |
| Target Price | $11.17 | ★ $55.68 |
| AVG Volume (30 Days) | ★ 2.4M | 2.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,932,576,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.01 | $0.30 |
| 52 Week High | $7.80 | $30.98 |
| Indicator | PEPG | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 22.68 | 93.44 |
| Support Level | $1.57 | $0.63 |
| Resistance Level | $5.46 | N/A |
| Average True Range (ATR) | 0.22 | 2.77 |
| MACD | 0.02 | 1.95 |
| Stochastic Oscillator | 12.25 | 94.51 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.